FDA notes that compounded drugs should generally be used only when a patients medical needs cannot be met by an FDA-approved drug or during recognized shortages, and that compounded GLP-1 products may carry additional risksincluding dosing errors or contaminationbecause they have not been evaluated for safety, effectiveness, or quality
Tolerability Issues : The adverse events with the GLP-1-based therapies are primarily gastrointestinal and include nausea, vomiting, constipation, or diarrhea [82], leading to meaningful discontinuation rates that limit real-world effectiveness
Dosage varies based on individual needs, but many studies on PCOS and insulin resistance use between 2,000mg and 4,000mg per day
Gather Evidence Related to Your Case: With the help of your legal team, you will need to gather evidence related to your case
Catching researchers eyes was its uncanny resemblance to human GLP-1, with a superpower: it sticks around in the body far longer
Russell-Jones D, Vaag A, Schmitz O, et al